1,3,4-oxadiazole has been researched along with Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acar Çevik, U; Ahmad, I; Celik, I; Işık, A; Kaplancıklı, ZA; Özkay, Y; Patel, H | 1 |
| Beshay, BY; El-Sadek, M; Fawzy, SM; Ibrahim, SM; Kothayer, H; Loksha, YM; Shamaa, MM | 1 |
| Ananth, AH; Bhattacharjee, A; Elancheran, R; Kabilan, S; Lakshmithendral, K; Manikandan, N; Rajan, RK; Ramanathan, M | 1 |
| Emam, SH; Kamal, AM; Khalil, NA | 1 |
4 other study(ies) available for 1,3,4-oxadiazole and Breast Cancer
| Article | Year |
|---|---|
Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
Topics: Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; HeLa Cells; Humans; Mice; Molecular Docking Simulation; Molecular Structure; NIH 3T3 Cells; Structure-Activity Relationship | 2023 |
Synthesis of 1,2,4-triazole and 1,3,4-oxadiazole derivatives as inhibitors for STAT3 enzymes of breast cancer.
Topics: Breast Neoplasms; Female; Humans; Molecular Docking Simulation; Molecular Structure; Oxadiazoles; STAT3 Transcription Factor; Structure-Activity Relationship | 2023 |
Design, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Breast Neoplasms; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferase 1; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estrogen Receptor alpha; Female; Humans; Imatinib Mesylate; Molecular Conformation; Molecular Docking Simulation; Oxadiazoles; Structure-Activity Relationship | 2020 |
Design, Synthesis, and Antitumor Activity of Novel 5-Pyridyl-1,3,4-oxadiazole Derivatives against the Breast Cancer Cell Line MCF-7.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; MCF-7 Cells; Oxadiazoles; Structure-Activity Relationship | 2015 |